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Alterations to the microbiota-colon-brain axis in high-fat-diet-induced obese mice
compared to diet-resistant mice
Abstract
Obesity is underpinned by both genetic and environmental factors, including a high-saturated-fat diet.
Some mice develop diet-induced obesity (DIO), but others remain diet resistant (DR) despite intake of the
same high-saturated-fat diet, a phenomenon that mimics characteristics of the human obese phenotype.
Microbiota-colon-brain axis regulation is important for energy metabolism and cognition. Using DIO and
DR mouse models, this study aimed to examine gut microbiota, colonic inflammation and cognitive
function to elucidate the role of microbiota-gut-brain regulation in DIO. C57Bl6/J mice fed a chronic
saturated-palmitic-acid diet for 22 weeks showed significant body weight gain differences, with the top
one third gaining 48% heavier body weight than the lower one third. There was significant reduction in gut
microbiota richness and diversity in DIO mice but not in DR mice. At the phylum level, DIO mice had
increased abundance of Firmicutes and Antinobacteria, and decreased abundance of Bacterioides and
Proteobacteria in gut microbiota. DIO mice exhibited reduced tight junction proteins, increased plasma
endotoxin lipopolysaccharide (LPS) and increased inflammation in the colon and liver. Recognition
memory and spatial memory were impaired in DIO mice, associated with decreased Bacteroidetes.
Further examination showed that hippocampal brain-derived neurotrophic factor was significantly
decreased in DIO mice (vs. DR). Conversely, DR mice showed no changes in the above parameters
measured. Therefore, gut microbiota, colon inflammation and circulating LPS may play a major role in the
development of the obese phenotype and cognitive decline associated with a chronic high-saturatedpalmitic-acid diet.
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Abstract:
Obesity is underpinned by both genetic and environmental factors, including a high
saturated fat diet. Some mice develop diet-induced obesity (DIO) but others remain
diet-resistant (DR), despite intake of the same high-saturated fat diet; a phenomenon
that mimics characteristics of the human obese phenotype. Microbiota-colon-brain
axis regulation is important for energy metabolism and cognition. Using DIO and DR
mouse models, this study aimed to examine gut microbiota, colonic inflammation and
cognitive function to elucidate the role of microbiota-gut-brain regulation in
diet-induced obesity. C57Bl6/J mice fed a chronic saturated palmitic acid diet for 22
weeks showed significant body weight gain differences, with the top one third gaining
48% heavier body weight than the lower one third. There was significant reduction in
gut microbiota richness and diversity in DIO mice, but not in DR mice. At the phylum
level, DIO mice had increased abundance of Firmicutes and Antinobacteria, and
decreased abundance of Bacterioides and Proteobacteria in gut microbiota. DIO mice
exhibited

reduced

tight

junction

proteins,

increased

plasma

endotoxin

lipopolysaccharide (LPS) and increased inflammation in the colon and liver.
Recognition memory and spatial memory were impaired in DIO mice, associated with
decreased Bacteroidetes. Further examination showed that hippocampal brain-derived
neurotrophic factor (BDNF) was significantly decreased in DIO mice (vs DR).
Conversely, DR mice showed no changes in the above parameters measured.
Therefore, gut microbiota, colon inflammation and circulating LPS may play a major
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role in the development of the obese phenotype and cognitive decline associated with
a chronic high saturated palmitic acid diet.
Keywords:
palmitic acid diet, obesity, gut microbiota, colonic inflammation, cognition, BDNF
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1 INTRODUCTION:
Diets rich in saturated fat can induce obesity, associated with insulin resistance and
cognitive decline. Palmitic acid (PA, C16:0) is the most common saturated fatty acid
in human diets in the modern society, accounting for approximately 65% of saturated
fatty acids and 32% of total fatty acids in human serum [1]. Patients with metabolic
syndrome have a significantly higher level of PA, but not other saturated fatty acids,
such as myristic acid or stearic acid within erythrocytes [2]. Obesity is a polygenic
disorder and results from a complex interaction with an obesogenic environment,
including saturated fat intake [3]. For example, mice or rats fed a high-fat diet either
develop obesity or resistance to obesity, but have comparable body weight when fed a
lab chow diet [4-7]. Interestingly, there are differences in gene expression between
diet-induced obesity (DIO) mice and their diet-resistant (DR) counterparts [8, 9],
showing clear genetic distinction between resistant and non-resistant rodents.
Therefore, DIO and DR models mimic some characteristics of the human obese
phenotype, including a polygenic mode of inheritance and the fact that some (but not
all) individuals are susceptible to weight gain when exposed to an obesogenic
environment [10].
The role of gut microbiota in contributing to obesity has been recognized. For
example, an imbalance of Firmicutes and Bacteroidetes, the primary bacterial phyla
comprising the gastrointestinal microbiota, has been reported in the leptin-deficient
ob/ob mouse model [10, 11]. Consistent with animal studies, similar differences with
an increase in the ratio of Firmicutes/Bacteroidetes has been found in the distal gut
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microbiota in obese individuals [12]. However, alterations in the gut microbiota in
obese individuals have not been reported by all investigators [13]. It has even been
reported that ratios of Firmicutes to Bacteroidetes are lower in some obese adults
compared to lean controls [14], whereas a study employing an 8-week high-saturated
fat diet altered gut microbiota with increased Firmicutes and reduced Bacteriodetes in
mice [15]. However, rare studies have examined microbiota in obesity in a manner
that encompasses the interaction between environmental and genetic factors using
DIO compared to DR phenotypes.
Obesity has been associated with a chronic low-grade level of inflammation.
Alterations in the gut microbiota may play a role in intestinal inflammation and
epithelial functions in the development of obesity. High-fat dietary intake increases
circulating plasma levels of lipopolysaccharide (LPS, endotoxin), a breakdown
product of outer layer of Gram-negative bacteria [16]. LPS and saturated fatty acids
exert effects on the toll-like receptor 4 (TLR4) [17], which is expressed at high levels
in the colon, but lower levels in the small intestine [18, 19]. TLR4 and its adaptor
protein, myeloid differentiation primary-response protein 88 (MyD88), activate the
inflammatory signaling pathway, including inhibitor kappa B alpha (IκBα) and
nuclear factor-kappa B (NFκB) [20]. In addition, intestinal macrophages are essential
for intestinal homeostasis and play critical roles in protective immunity and
inflammation [21, 22]. The colon has a high density of macrophages compared to
other parts of the gastrointestinal tract [23]. In the healthy mouse colon, most resident
macrophages are resistant to TLR stimulation and express anti-inflammatory markers,
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such as CD206, to prevent inflammation [24]. On the other hand, experimental colitis
results in the accumulation of TLR-responsive pro-inflammatory macrophages, most
of which become CD11c+ and F4/80+, indicating upregulated pro-inflammatory
actions [24]. A recent report showed that colonic pro-inflammatory macrophages play
a causal role in the development of insulin resistance, as decreased infiltration of
colonic pro-inflammatory macrophages improved high-fat diet-induced insulin
resistance in macrophage-specific chemokine (C-CMotif) receptor 2 (Ccr2) knockout
(M-Ccr2KO) mice [25]. Another study found that the switch from anti-inflammatory
to pro-inflammatory macrophages occurred in adipose and muscle tissue, as well as
the liver and pancreas, contributing to insulin resistance in obesity [26]. However, the
status of macrophages in the colon of DIO and DR mice requires further investigation.
Furthermore, the role of colonic inflammation in generating obesity induced by a high
saturated fat diet and altered gut microbiota is unknown.
Evidence shows a link between gut microbiota, central levels of brain-derived
neurotrophic factor (BDNF) and cognitive behavior. For example, one study showed
that administration of gut bacteria Citrobacter rodentium by oral gavage caused
memory dysfunction in mice exposed to stress conditions

[27], while another

reported that oral antimicrobial treatment transiently altered the composition of the
microbiota and increased hippocampal BDNF expression [28]. On the other hand,
reduced BDNF expression in the hippocampus contributes to working-memory
impairment in germ-free mice [27]. These studies suggest that BDNF may be
influenced by gut microbiota, causing effects on cognitive function. However, it is not
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known whether cognition and altered BDNF levels are affected by a diet high in
saturated palmitic acid or by the presence of obesity, and whether alterations in these
factors occur concurrently with altered gut microbiota.
A useful tool in preclinical obesity research to study the interaction between diet
and genes is the C57 male mouse model, incorporating mice genetically prone to
diet-induced obesity and their diet-resistant counterparts. When exposed to a high-fat
diet, the DIO mice gain weight and become obese, while the DR mice remain as lean
as the control mice. Therefore, the DIO and DR mouse model can provide insight into
whether changes in the gut microbiota, colon inflammation and cognition are driven
by the high saturated PA diet or by the ensuing obesity. In the current study, by using
both chow- and PA diet-fed DIO and DR mice, we determined whether shifts in the
microbiota profile result solely from the consumption of an obesogenic PA diet or are
a manifestation of the obese phenotype. Furthermore, we examined levels of LPS (an
endotoxin) in plasma, colonic tight junction protein levels (reflecting the permeability
of colon epithelia), macrophage shifting towards a pro-inflammatory phenotype and
markers of inflammation in the colon, as well as hippocampal BDNF and cognitive
behavior.

2 MATERIALS AND METHODS:
2.1 Animals and treatments
Seventy-two C57Bl/6J male mice (6 weeks old) were obtained from the Animal
Resources Center (Perth, WA, Australia). They were housed in environmentally
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controlled conditions (temperature 22°C, 12 hour light/dark cycle), and allowed ad
libitum access to food and water through-out the study. Mice were fed standard
laboratory chow (ie low fat (LF) diet, AIN93M, Speciality Feeds, WA, Australia) for
the first week to facilitate habituation to the new environment, then randomized into
dietary treatment groups. The first group of mice (n=18) was fed a LF diet as a
control, while the second group (n=54) was fed a high PA diet for 22 weeks. High PA
diets were custom-made by Specialty Feeds (SF15-080, WA Australia) and contained
300 g/kg as fat (30%), including 100 g/kg palmitate (ie palmitate equivalent to 30% of
total fat composition). The rationale for choosing this lipid composition was based on
the average saturated fat content of a hamburger (ie a typical modern Western human
fast food meal item), which can be more than 30%. The LF diet was used as a control,
with a crude fat content of 4% (PA, 0.008%). After consuming the high PA diet for
8-weeks, the mice with the highest body weight gain were designated as the DIO mice
(n=18), while mice with the lowest body weight gain were designated as the DR mice
(n=18), according to methods we have previously published [29, 30] Mice with an
intermediate body weight gain were removed from this study.
After 19 weeks of consuming either a high PA or LF diet, mice underwent an
intraperitoneal glucose tolerance test (IPGTT, Section 2.2 below), followed by a
series of behavioural tests in weeks 20-21 (Section 2.3). Mice were sacrificed after
22-weeks of dietary treatment, 4 days after behavioural testing. Four fat pads (Inguinal,
Epididymal, Perirenal, Mesenteric) were excised and weighed. Each group of mice
(n=18) were further divided into 3 subgroups (n=6) for tissue examination:
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immunohistochemistry in colon and liver after fixing tissue; Western blot in colon and
liver; In situ in brain and microbial diversity analysis in cecal content. Samples of
plasma, intestine and cecal content, as well as liver and brain tissues were collected
and stored at -80 °C for further analyses. All experimental procedures were approved
by the Animal Ethics Committee, University of Wollongong, Australia, and all animal
experiments were conducted in compliance with National Health and Medical
Research Council (NHMRC) Australian Code of Practice for the Care and Use of
Animal for Scientific Purposes (2004).

2.2 Intraperitoneal glucose tolerance test (IPGTT)
The IPGTT was conducted as we have previously described [31]. Briefly mice
were fasted overnight followed by an intraperitoneal injection of glucose (0.5 g/kg;
Sigma-Aldrich, St Louis, MO, USA). Blood samples were obtained from the tail vein
at 0, 30, 60 and 120 minutes following the injection of glucose. Blood glucose levels
were measured in duplicate using an Accu-Chek glucometer (Roche Diagnostics
GmbH Mannheim, Germany).

2.3 Behavioral tests
The Y-maze and novel object recognition tests were performed in order to
examine dietary effects on spatial and recognition memory. Tests were conducted
based on methods previously published [32, 33] (see Supporting Information for
detailed methods). In the Y-maze test, the ratio of time spent in the novel arm (a
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ratio of the amount of time spent in the novel arm over the total time spent in all
three arms) was used to evaluate spatial memory. For the novel object recognition
test, the discrimination index ([(Novel object exploration time/Total exploration
time)−(Familiar object exploration time/Total exploration time)]×100) was used to
evaluate recognition memory.

2.4 Plasma leptin and adiponectin
Post-mortem blood was collected directly from the heart into a heparin coated tube.
Blood samples were centrifuged at 4000rpm for 10 minutes (4oC) and plasma was
collected. Using the mouse endocrine Lincoplex kit (Cat.# MENDO-75K, Linco
Research, St Louis, MO, USA), the plasma levels of leptin and adiponectin were
determined.

2.5 Haematoxylin and eosin (H & E) staining
Paraffin-embedded liver sections (5µm) were stained with hematoxylin and eosin.
The histological parameters (steatosis and ballooning) were scored using a method
described in our previous study [34] (see Supporting Information for detailed
methods).

2.6. Immunohistochemistry
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The immunohistochemical staining method for liver or colon sections was
conducted using the protocol we have previously published [34] (see Supporting
Information for detailed methods).

2.7 Western blotting
Colon tissues were dissected and homogenized in a NP-40 lysis buffer (containing
NP40, Protease Inhibitor Cocktail, 1 mM PMSF and 0.5 mM β -glycerophosphate).
Total protein concentrations were determined by DC-Assay (Bio-Rad, Hercules, CA)
and detected using a SpectraMax Plus384 absorbance microplate reader (Molecular
Devices, Sunnyvale, CA). The Western blot method was conducted as described in
our previous study [35] (see Supporting Information for detailed methods).

2.8 Lipopolysaccharide (LPS) determination
The concentration of circulating plasma LPS was measured by enzyme-linked
immunosorbent assay (LAL assay kit, Hycult Biotech, The Netherlands). The
absorbance was measured at 405 nm using a spectrophotometer, with measurable
concentrations ranging from 0.04 to 10 EU/ml. All samples for LPS measurements
were performed in duplicate.

2.9 Microbial diversity analysis
2.9.1 DNA extraction and PCR amplification
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Microbial DNA was extracted from cecal content using the E.Z.N.A.® stool DNA
Kit (Omega Bio-tek, Norcross, GA, U.S.) according to manufacturer’s protocols. The
V4-V5 regions of the bacteria 16S ribosomal RNA gene were amplified by PCR (95
°C for 2 min, followed by 25 cycles at 95 °C for 30 s, 55 °C for 30 s, and 72 °C for
45 s with a final extension at 72 °C for 5 min) using primers 338F 5’-barcodeACTCCTACGGGAGGCAGCAG)-3’

and

806R

5’-GGACTACHVGGGTWTCTAAT-3’, where the barcode was an eight-base
sequence unique to each sample. PCR reactions were performed in triplicate with
20 µL mixture containing 4 µL of 5 × FastPfu Buffer, 2 µL of 2.5 mM dNTPs, 0.8 µL
of each primer (5 µM), 0.4 µL of FastPfu Polymerase, and 10 ng of template DNA.

2.9.2 Illumina MiSeq sequencing
Amplicons were extracted from 2% agarose gels and purified using the AxyPrep
DNA Gel Extraction Kit (Axygen Biosciences, Union City, CA, USA) according to
the manufacturer’s instructions and quantified using QuantiFluor™ -ST (Promega,
U.S.). Purified amplicons were pooled in equimolar and paired-end sequenced (2 ×
250) on an Illumina MiSeq platform according to standard protocols.

2.9.3 Processing of sequencing data
Raw fastq files were demultiplexed, quality-filtered using QIIME (version 1.17)
with the following criteria: (i) The 300 bp reads were truncated at any site receiving
an average quality score <20 over a 50 bp sliding window, discarding the truncated
reads that were shorter than 50bp. (ii) exact barcode matching, 2 nucleotide mismatch
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in primer matching, reads containing ambiguous characters were removed. (iii) only
sequences that overlap longer than 10 bp were assembled according to their overlap
sequence. Readings that could not be assembled were discarded.
Operational Units (OTUs) were clustered with 97% similarity cut-off using
UPARSE (version 7.1 http://drive5.com/uparse/) and chimeric sequences were
identified and removed using UCHIME. The taxonomy of each 16S rRNA gene
sequence was analyzed by RDP Classifier (http://rdp.cme.msu.edu/) against the silva
(SSU115)16S rRNA database using confidence threshold of 70%.

2.10 In situ hybridization
Coronal brain sections (14 µm) sections were collected from Bregma +0.14mm to
-2.92mm according to a standard mouse brain atlas [36]. The hybridization
procedures and mRNA quantification were described in our previous study [37] (see
Supporting Information for detailed methods).

2.11 Statistical analysis
Data were analyzed using the statistical package SPSS (version 20, IBM
Corporation, Chicago, IL, USA). Data was first tested for normality before
differences among the DIO, DR and LC groups were determined using one-way
analysis of variance (ANOVA). This was followed by the post hoc Tukey-Kramer
honestly significant difference (HSD) test for multiple comparisons among the
groups. A p value of <0.05 was considered to be statistically significant. Values were
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expressed as mean ± SEM. Pearson’s correlations were used to examine the
relationships between the parameters in the behavior tests and Bacteroidetes as well as
plasma LPS and tight junction proteins in colon.

3 Results:
3.1 Chronic PA diet increased body weight, adiposity, food intake, and hepatic
injury in DIO mice
On a chronic high PA diet, the DIO mice gained significantly more body weight
than the DR and LF mice from 5 weeks and this persisted throughout the rest of the
dietary intervention (Fig. 1A). The final body weight of DIO mice was 48% and 54%
heavier than that of DR and LF mice (both P < .01) (Fig. 1B). Moreover, DIO mice
consumed significantly more calories compared to the DR (P < .05) and LF mice (P
< .05) (Fig. 1C). The DIO mice had higher inguinal, epididymal, perirenal and
mesenteric fat masses compared to DR and LF mice (Fig. 1D). Furthermore, the DIO
mice also had higher fat ratios after normalized to body weight (Fig. 1E). The IPGTT
revealed that the DIO mice had an impaired glucose tolerance (Fig. 1F). The blood
glucose levels of DIO mice significantly increased at 0, 15, 30, 60, and 120 minutes
during the IPGTT compared to the DR and LF mice (All P < .05). Leptin and
adiponectin are secreted from adipose tissue and have anti-obesity effects [38], but the
DIO mice exhibited hyperleptinemia and a low ratio of plasma adiponectin to visceral
fat (Fig. 1G-I), suggesting leptin resistance and impaired secretion of adiponectin in
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these mice. Therefore, even though the DIO and DR mice were exposed to the same
obesogenic diet and housed under the same conditions, the results suggest some
genetic variations that contribute to the susceptibility of gaining weight on a high
saturated-fat diet.

3.2 Chronic PA diet-induced DIO and DR mice have different gut microbiota
profiles
Bacterial communities within the feces were determined by Illumina MiSeq
sequencing of 16S rRNA genes and resulted in the recovery of 1604,201 effective
sequences with a read length ≥ 360 bp. After quality filtering by QIIME, 1497,652
high-quality reads were obtained, accounting for 93.36% of the raw reads.
Out of the 318 bacterial species-level operational taxonomic units (OTUs) found in
this study, 295 were found in LF and DR mice; only 272 were found in DIO mice.
There were 252 OTUs shared by LF, DR and DIO groups. There were 23 OTUs
shared by LF and DR mice, while there were only 6 OTUs shared by LF and DIO
mice and 11 OTUs shared by DIO and DR mice (Fig. 2A). Furthermore, DIO mice
had lower species richness than DR and LF mice [Chao 1 index (OTUs), DIO:
176.75±10.18, DR: 203.10±11.04; LF: 210.45±11.31, P < .05)]; and had lower
species diversity than that of DR and LF mice [Shannon index (OTUs), DIO: 3.05 ±
0.34; DR: 4.07 ± 0.38; LF: 4.05 ± 0.37, P < .05] (Fig 2B). There was no significant
difference in Chao1 and Shannon indices between LF and DR mice.
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At the phyla level, the abundance of Firmicutes was higher in DIO mice compared
to DR and LF mice (P < .05, Fig 2C), while there was no significant difference
between DR and LF mice. The abundance of Bacteroidetes was lower in DIO and DR
mice compared with LF mice, while DIO mice had a lower abundance than that of DR
mice (P < .05, Fig 2C), suggesting that Bacteroidetes was not only decreased in
obesity, also decreased by HF diet in DR mice without significant body weight gain.
Similarly, the ratio of Firmicutes to Bacteroidetes in DIO mice and DR mice was
significantly higher than LF mice (both P < .05, Fig 2D), while the DIO mice had the
highest ratio. The abundance of Antinobacteria in DIO mice and DR mice were
significantly higher than that of LF mice (both P < .05, Fig 2E) with the highest level
in DIO mice. The abundance of Proteobacteria was lower in DIO group, but higher in
the DR group compared to that of the LF group (both P < .05, Fig 2E).
When comparing the microbiota of DIO, DR and LF mice using LDA effect size
(LEfSe) calculation, we found 30 differentially abundant taxonomic classes (P < .05)
with an LDA score higher than 2.0 (Fig 2F). The results showed that phylum
Actinobacteria,

class

Actinobacteria,

order

Bifidobacteriales,

family

Bifidobacteriaceae and genus Bifidobacterium were all significantly increased in DIO
mice.

Notably,

bacteria

belonging

to

order

Clostridiales

Ruminococcaceae_nk4a214_group, Family_XIII_AD3011_group and Family_XIII
were increased significantly in DR mice and an unidentified genus of family
Erysipelotrichaceae was also increased significantly in DR mice (P < .05, Fig 2F).

17

3.3 Chronic PA diet altered colonic tight junction protein expression and
induced hyperendotoxinemia in DIO, but not DR mice.
To further determine whether changes in the gut microbiota could be associated
with the epithelial permeability and systemic inflammation, we measured levels of
tight junction protein expression and the plasma concentration of LPS, a trigger of
inflammation. The epithelial cells in the colon are tightly bound by intercellular
junctional protein complexes, occludin and zonula occludens (ZO-1), which regulate
paracellular permeability and are crucial for the integrity of the epithelial barrier [39].
Both occludin and ZO-1 expression decreased significantly in the colon of DIO mice
compared to DR and LF mice (all P < .01; Fig. 3A and B). Next, we found that the
level of serum LPS significantly increased in DIO mice compared to DR and LF mice
(both P < .01; Fig. 3C). There were significant negative associations between levels
of serum LPS and the concentrations of occludin (r = -0.631, p = 0.005) and ZO-1 (r =
-0.929, P < .001) (Fig. 3D and E), suggesting hyperendotoxinemia in DIO mice was
associated with impaired tight junction in the colon.

3.4 Chronic PA diet induced inflammation in the colon of DIO but not DR mice.
It is known that inflammation increases intestinal epithelial tight junction
permeability [40]. As levels of tight junction protein expression was reduced in the
DIO mice in the present study, we further examined macrophage infiltration and
inflammatory response in the colon of these mice. The positive immunoreactivity of
F4/80 was significantly increased in the colon of DIO mice compared to DR and LF
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mice (both p <0.01; Fig. 4A and B). Furthermore, we characterized the type of
macrophages present. CD11c was used to detect M1 macrophages, which produce
pro-inflammatory cytokines, and CD206 was used to detect M2 macrophages, which
produce anti-inflammatory cytokines. The DIO mice had increased CD11c positive
staining in the colon compared to DR and LF mice (both p <0.05; Fig. 4 A and C).
There was no significant difference in CD206 staining among the DIO, DR and LF
mice (Fig. 4 A and D). This indicates that the high PA diet promotes a shift in a
pro-inflammatory M1 polarization in the colon of obese mice.
As the pro-inflammatory M1 macrophage is TLR4-responsive and often associated
with low grade inflammation in local tissue, we measured the expression of TLR4 and
its adaptor protein, MyD88, as well as downstream signaling molecules (NFκB, IκBα
and pIκBα) and pro-inflammatory cytokines (tumor necrosis factor-α (TNF-α),
interleukin-1β (IL-1β) and interleukin-6 (IL-6)) in the colon by Western blotting. The
levels of TLR4 and MyD88 were higher in DIO mice than that of DR and LF mice
(all p <0.05; Fig. 4E and G). NFκB and pIκBα significantly increased in DIO mice
compared to DR and LF mice, while IκBa decreased in the colon of DIO mice. The
levels pro-inflammatory cytokines, TNFα, IL-1β and IL-6, were higher in DIO mice
than the DR and LF mice (all P < .05; Fig. 4F and H). In the colon tissue, the level of
cyclooxygenase isoform 2 (COX-2, a pro-inflammatory marker implicated in
colorectal cancer progression [41]) was increased in DIO mice, but not DR mice
compared to LF mice (both P < .05; Fig. 4F and H).
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3.5 Chronic PA diet induced hepatic inflammation in the DIO but not DR mice.
It has been reported that LPS binds to LPS-binding proteins in the liver, which then
facilitate its transfer to CD14 receptors on the surface of the macrophages and activate
the TLR4 signaling pathway [42]. Therefore, we examined hepatic pro-inflammatory
signaling molecules in the DIO and DR mice. Firstly, the liver weight was heavier in
DIO mice compared to DR and LF mice (both P < .01; Fig. 5A and B), and the ratio
of liver weight to body weight was higher in DIO mice compared to DR and LF mice
(both P < .05; Fig. 5C). Furthermore, At a histological level, the diagnostic criteria
for hepatic steatosis includes the presence of steatosis and ballooning [43]. H & E
staining revealed that the hepatocytes of DIO mice were enlarged and contained large
cytoplasmic lipid droplets compared to the DR group (ballooning: + 274%, P < .001;
steatosis: + 361%, P < .001) and LF mice (ballooning: + 319%, P < .001; steatosis: +
391%, P < .001) (Fig. 5D and E). Moreover, the levels of TLR4, MyD88 and NFκB
(inflammatory signaling molecules) were increased in the liver of DIO mice
compared to DR and LF mice, while there was no significant difference between DR
and LF mice (Fig. 5F and G). Therefore, DIO mice exhibited hepatic inflammation
and steatosis, symptoms reportedly associated with insulin resistance and glucose
intolerance [44]; the latter of which was also observed in these mice (see Section 3.1).

3.6 Chronic PA diet impaired cognitive function in DIO mice and reduced
hippocampal BDNF expression
Studies show that cognition and BDNF levels are affected by alterations to gut
microbiota [27, 28]. Therefore, we examined recognition and spatial memory, and
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hippocampal BDNF levels in DIO mice (ie in the presence of concurrent altered gut
microbiota). In the Y maze test, spatial memory was impaired in DIO mice, who
showed a significant reduction in the ratio of time spent in the novel arm compared to
the LF and DR mice (both P < .05; Fig. 6A). In novel object recognition test, the DIO
mice showed a significant reduction in the discrimination index compared with LF
and DR mice (both P < .01; Fig. 6B), suggesting the impairment of recognition
memory. Recent studies have demonstrated a clear association between changes in
microbiota and cognitive behavior [45]. Here, the Pearson’s correlation analysis
revealed a significant positive correlation between the abundance of Bacteroidetes and
cognitive behavior, including the ratio of time spent in novel arm (r = 0.65, p = 0.003)
and discrimination index (r =0.80, P < .001) (Fig. 6C and D). Next, in-situ
hybridization was used to examine the level of hippocampal BDNF mRNA
expression, which is implicated in spatial and recognition memory. The level of
BDNF mRNA expression was significantly decreased in the hippocampus, including
the CA1-3 and DG regions, in DIO mice compared to DR and LF mice (P < .05; Fig.
6E and F).

4 DISCUSSION
In this study, we found that some mice developed obesity whilst others were
diet-resistant and remained lean when fed the same chronic high PA diet. There was a
significant reduction in gut microbiota richness and diversity in the DIO mice, but not
the DR mice. DIO mice had reduced tight junction protein expression, increased
plasma LPS and increased inflammation in colon and liver. The gut microbiota (e.g.
Bacteroidetes) is important for cognitive function [46]; in this study, we found that
recognition and spatial memory were impaired in the DIO mice, with concurrent
decreased abundance of Bacteroidetes and hippocampal BDNF mRNA expression.
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On the other hand, the DR mice did not exhibit changes in colonic tight junction
protein expression, levels of plasma LPS, inflammatory response in the colon and
liver, or cognitive performance, although minor alterations in some gut microbiota at
phylum level were observed compared to the LF controls.
In the present study, we found that the richness (Chao1 index) of gut microbiota
was decreased in the DIO, but not in the DR mice. This is consistent with a human
study in which individuals with a low bacterial richness exhibited more adiposity, as
well as insulin resistance and dyslipidaemia, and a more pronounced inflammatory
phenotype compared to individuals with a high bacterial richness [16]. Furthermore,
the study found that obese individuals with the lower bacterial richness also gained
more weight over a 9 year period compared to subjects with a high bacterial richness.
Therefore, our results, combined with the human findings[16], provide evidence that
alterations in our second genome - the gut microbiota - may contribute to the
heterogeneity associated with adiposity-related phenotypes. Furthermore, the diversity
(Shannon index) of gut microbiota was decreased in the DIO mice. At the phylum
level, the abundance of Gram-negative Bacteroidetes and Proteobacteria were
decreased in DIO mice. Interestingly, in DR mice, the abundance of Bacteriodetes
was also decreased, but Proteobacteria was increased compared to the LF control
mice. LPS is a major component of the outer layer of Gram-negative bacteria and
plasma LPS levels are closely correlated with the Gram-negative Bacteroides-like
intestinal bacteria [47]. An elevated level of plasma LPS was previously related to the
over-production of LPS in the gut by the death of Gram-negative bacteria and their
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translocation into the blood circulation [47, 48]. In the present study, the plasma LPS
increased in DIO mice, but not in DR mice, suggesting that endotoximia in obesity
may result from the dysbiosis of Gram-negative bacteria (specifically, a decrease in
both Bacteroidetes and Proteobacteria), while an increased proportion of
Proteobacteria in DR mice may, to some degree, compensate for decreased levels of
Bacteroidetes.
Furthermore, we found that DIO mice consumed more calories. The reason of DIO
mice consumes more calories could be due to multiple factors. It could be due altered
regulation of gut-brain axis induced by an interaction of genetic and environment
factors (such as high-fat diet). For example, previously we found that in DIO mice
there is decreased gut anorexigenic peptide YY (PYY)-central neuropeptide Y (NPY)
Y2 receptor axis, which plays an important role in promoting negative energy balance
regulation[49]. Furthermore, Y2 receptor binding is also lowered in the hypothalamus
in DIO mice when their body weight is similar as DR mice with energy restriction
diet, suggesting a possible intrinsic nature of the DIO mice in response to
high-fat diet.
Furthermore, we found that expression of the tight junction proteins, occludin and
ZO-1, decreased in the colon of DIO mice. The tight junction protein complex seals
the paracellular space between epithelial cells, thus preventing paracellular diffusion
of luminal microorganisms and their fragments, such as LPS. In the present study,
there was a negative correlation between the levels of hyperendotoxinemia and tight
junction proteins, occludin and ZO-1, in the colon. Furthermore, levels of
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pro-inflammatory M1 macrophages stained with CD11c were increased in the colon
of DIO mice without a concurrent alteration in anti-inflammatory M2 macrophage
(CD206-positive) levels. Our finding indicates there is a shift in macrophage subtype
to a pro-inflammatory M1 polarization in the colon of high palmitic acid diet-induced
obesity. To our knowledge, it is firstly to report a M1 macrophage shift in the colon
during obesity induced by high palmitic acid diet. It has been reported that
anti-inflammatory M2 macrophages can shift into M1 macrophages to promote
inflammation following LPS stimulation [50]. Therefore, the hyperendotoxinemia in
DIO mice may contribute to the M1 pro-inflammatory macrophage shift in colon, in
which most resident macrophages are normally M2 expressing CD206 to prevent
inflammation [51].
TLR4 receptors are highly expressed in the colon compared to other parts of the
intestine [18, 19]. Not only does LPS activate the TLR4 receptor, but palmitic acid
also interacts with this receptor [52]. In the present study, TLR4 levels were elevated
in the colon tissue of DIO mice. Therefore, an abundance of palmitic acids in the
colon and over production of LPS from the microbiota may activate TLR4 in colon in
the DIO mice. TLR4-MyD88-dependent pathway activates IκB-NFκBβ [20]. NFκB, a
transcription factor, can promote the transcription of pro-inflammatory genes, such as
IL-6 and TNFα, which in-turn can directly propagate tumorigenesis. In the colon,
TLR4 expression is associated with adenocarcinoma and increased risk of disease
progression. Saturated fatty acids modulate TLR4-mediated NFκB signaling pathways
and increase COX2 [53], which plays important roles in inflammation and cancer
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progression [47]. Epidemiological data suggest that obesity is associated with a
30-70% increased risk of colon cancer in human [54]. Previously, we have reported
that DIO mice develop colon polyps at a rate 2.5 times greater than the DR mice [55].
Therefore, activation of TLR4 and its downstream signaling pathway MyD88-NFκB
in the colon tissue may contribute to colonic inflammation and polyp formation and
obesity-related colon cancer.
In the present study, the use of a novel object recognition test and exploration of a
Y-maze demonstrated that recognition and spatial memory were impaired in
high-palmitic acid induced obese mice (DIO), in which hippocampal BDNF levels
were also decreased. Previous studies have highlighted a link between BDNF,
microbiota and cognition behavior. For example, cognitive dysfunction is apparent in
mice exhibiting altered hippocampal BDNF levels following an induced enteric
infection, ~30 days post-inoculation [27]. Moreover, intraperitoneal administration of
LPS in mice leads to reduced hippocampal BDNF and cognitive defects [56]. In the
present study, alterations to gut microbiota in diet-induced obesity might be
responsible for the observed cognition decline. We found a correlation between
decreased Bacteroidetes and alterations in cognitive behaviors, but proof of a direct
cause and effect mechanism is still required. Nevertheless, this correlation is further
supported by a recent study reporting that Bacteroides in the infant gut (at 1 year of
age) has a role in cognitive development and brain morphometry [46]. A higher
abundance of Bacteroides at 1 year of age has been correlated with a higher cognitive
ability (based on an overall composite score), as well as improved expressive
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language subscale when measured again at age 2 years of age [46]. However, further
studies on the gut microbiota-brain axis in diet-induced obesity are required. For
example, future studies could examine cognitive behavior in normal weight, LF diet
mice following transplantation of fecal microbiota obtained from palmitic-acid
diet-induced obese mice, or whether supplementation of Bacteroide-rich microbiota
can improve cognition in diet-induced obese mice.
In conclusion, this study has showed that a diet high in obesogenic palmitic acid
induced some mice to become obese, while others remained lean, despite being fed
the same diet. The response in microbiota, colon and brain of diet-induced obesity
was investigated in mice prone and resistant to obesogenic diet. The obese mice had
decreased richness and diversity of gut microbiota, a pro-inflammatory M1
macrophage shift and impaired tight junctions between epithelial cells of the colon,
with an ensuing increase in plasma levels of the endotoxin, LPS. In addition,
recognition and spatial memory were impaired in obese mice, with concurrently
reduced hippocampal BDNF levels. Conversely, there were no significant alterations
in colonic tight junction proteins, plasma LPS, colonic inflammation, or cognitive
performance in mice resistant to obesity compared to lean (LF-diet) mice. Taken
together, these data suggest that gut microbiota, colon inflammation and LPS may
play a major role in the development of the obese phenotype and cognitive decline in
high palmitic acid diet-induced obesity. Furthermore, this study did not examine
microbiome prior to obesity phenotype which will be our future study.
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FIGURE LEGENDS:

Fig. 1. (A) Body weight gain, (B) final body weight, (C) energy intake, (D) fat mass, (E)
the ratio of fat pad weight to body weight, (F) intraperitoneal glucose tolerance test,
(G) plasma leptin, (H) plasma adiponectin, and (I) ratio of adiponectin to visceral
(Visc.) fat in diet-induced obese (DIO), diet-resistant (DR) and low-fat (LF) diet fed
mice. * P < .05 vs. LF. # P < .05 vs. DR. Values are mean ± SEM, n=18.

Fig. 2. The gut microbial communities in diet-induced obese (DIO), diet-resistant (DR)
and low-fat (LF) diet fed mice. (A) Venn diagrams comparing the OTU memberships,
(B) richness (Chao 1 index) and diversity (Shannon index) of gut microbial
communities based on out, (C) abundance of Firmicutes and Bacteroidetes, (D) ratio of
Firmicutes (FM) to Bacteroidetes (BO), (E) abundance of Antinobacteria and
Proteobacteria, (F) LEfSe results on mice gut microbiomes. Values are mean ± SEM, n
= 6. * P < .05 vs. LF. # P < .05 vs. DR.

Fig. 3. (A and B) Protein expression levels of occludin and zonula occludens-1 (ZO-1) in
the colon, (C) plasma LPS levels, and correlations between plasma LPS levels and
colonic (D) occludin or (E) ZO-1 expression in diet-induced obese (DIO), diet-resistant
(DR) and low-fat (LF) diet fed mice. Values are mean ± SEM, n=6. * P < .05 vs. LF. #
P < .05 vs. DR.

Fig. 4. Inflammatory markers in the colon. (A) Immunohistochemical staining;
percentage of (B) F4/80-, (C) CD11c- and (D) CD206-positive cells, (E and G) colonic
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protein expression levels of TLR4, MyD88, NFκB, IκBα and p-IκBα, and (F and H)
colonic protein expression levels of TNF-α, IL-1β, IL-6 and COX2, in diet-induced
obese (DIO), diet-resistant (DR) and low-fat (LF) diet fed mice. Values are mean ±
SEM, n=6. * P < .05 vs. LF. # P < .05 vs. DR. Scale bar: 80 µM.

Fig. 5. (A) Fresh liver appearance, (B) liver weight, (C) liver weight / Body weight,

(D)

hematoxylin and eosin staining of liver, (E) index of hepatic steatosis and cellular
ballooning, and (F and G) protein expression levels of TLR4, MyD88 and NFκB in the
liver of diet-induced obese (DIO), diet-resistant (DR) and low-fat (LF) diet fed mice.
Values are mean ± SEM, n=6. * P < .05 vs. LF. # P < .05 vs. DR. Scale bar: 10 µM

Fig. 6. (A) The ratio of time spent in novel arm in the Y maze test, (B) discrimination
index in the novel object recognition test, and correlation between levels of gut
Bacteroidetes and (C) ratio of time spent in the novel arm or (D) discrimination index,
and (E and F) hippocampal BDNF mRNA levels in diet-induced obese (DIO),
diet-resistant (DR) and low-fat (LF) diet fed mice. Values are mean ± SEM, n=12 in
(A) and (B); n=6 in (C, D, E, F). * P < .05 vs. LF. # P < .05 vs. DR. Scale bar: 50 µM.
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